GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Equity-to-Asset

Vitrolife AB (OSTO:VITR) Equity-to-Asset : 0.78 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vitrolife AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr13,231 Mil. Vitrolife AB's Total Assets for the quarter that ended in Mar. 2024 was kr16,873 Mil. Therefore, Vitrolife AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.78.

The historical rank and industry rank for Vitrolife AB's Equity-to-Asset or its related term are showing as below:

OSTO:VITR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.68   Med: 0.82   Max: 0.94
Current: 0.78

During the past 13 years, the highest Equity to Asset Ratio of Vitrolife AB was 0.94. The lowest was 0.68. And the median was 0.82.

OSTO:VITR's Equity-to-Asset is ranked better than
71.43% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs OSTO:VITR: 0.78

Vitrolife AB Equity-to-Asset Historical Data

The historical data trend for Vitrolife AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Equity-to-Asset Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.87 0.79 0.81 0.78

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.82 0.82 0.78 0.78

Competitive Comparison of Vitrolife AB's Equity-to-Asset

For the Medical Devices subindustry, Vitrolife AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Equity-to-Asset falls into.



Vitrolife AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vitrolife AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=12722/16329
=0.78

Vitrolife AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=13231/16873
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB  (OSTO:VITR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Vitrolife AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (OSTO:VITR) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines